Congenital diaphragmatic hernia with congenital heart disease including ventricular septal defect: Risk factors

Yuichi Hirano1, Keita Terui1, Wataru Kudo1

  • 1Department of Pediatric Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Insights

Congenital diaphragmatic hernia (CDH) with ventricular septal defect (VSD) has a poor prognosis. Low lung volume is a key risk factor for mortality in these infants, similar to isolated CDH cases.

Area of Science:

  • Pediatric Surgery
  • Neonatal Cardiology
  • Medical Genetics

Background:

  • Congenital diaphragmatic hernia (CDH) significantly impacts neonatal outcomes, especially when associated with congenital heart disease (CHD).
  • Ventricular septal defect (VSD) is the most frequent CHD complication in CDH cases, contributing to poor prognosis.
  • Identifying prognostic factors is crucial for managing CDH with VSD.

Purpose of the Study:

  • To determine the prognostic factors for CDH associated with VSD.
  • To compare outcomes between survivors and non-survivors in a cohort of neonates with CDH and VSD.

Main Methods:

  • A retrospective observational study was conducted on neonatal CDH with CHD cases from 2000-2022.
  • Risk factors for CDH with VSD were analyzed by comparing survivors and non-survivors.
  • Prenatal diagnosis and lung volume metrics were assessed.

Main Results:

  • Of 84 CDH infants, 14 had CHD, with 11 cases of VSD (79% of CHD).
  • Survival rate for CDH with prenatal diagnosis of left-sided disease and VSD was 56%.
  • Low lung volume (observed/expected lung area-to-head circumference ratio ≤ 35%) was significantly higher in non-survivors (75% vs. 0%, p=0.048). Non-survivors also had severe CHD or pulmonary hypertension.

Conclusions:

  • Low lung volume is a significant risk factor for CDH with VSD, impacting survival.
  • This finding is comparable to prognostic factors in isolated CDH cases.
  • Early identification of low lung volume is critical for managing CDH with VSD.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
51
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
79
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
51
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
66
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
53